secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K/A
Filed at:   2023-09-26T23:59:59+00:00
Accession:  0001628908-23-000141
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent restates NIA financials; KPMG withdraws report on revenue recognition error
--------------------------------------------------------------------------------

- KPMG withdrew its audit opinion on NIA's 2020/2021 financials due to error in applying ASC 606 (gross vs net revenue recognition).
- Restated NIA financials now recognize risk-based contract revenue net; net income unchanged for all periods.
- Evolent's own financial statements, 2023 guidance, and NIA valuation unaffected by the error.
- Restated audited combined financials for Magellan Specialty Health for 2020 and 2021 filed as Exhibit 99.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000141/0001628908-23-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000141/evh-20230119.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer